SI-BONE, Inc. (SIBN) stock
SIBNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3048% above fair value
$23.73−0.02 (-0.08%)
Close on Nov 20, 2026Market cap $1.06BP/E –Yield 0.00%
Si-Bone net income
Net income is the profit left for shareholders after every expense, interest and tax.
Si-Bone's net income for the twelve months ending Jun 30, 2026 was -$14.63M. For fiscal 2025 it was -$18.90M. The highest annual figure on record is -$17.45M in fiscal 2018.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$18.90M | – |
| FY2024 | Dec 31, 2024 | -$30.91M | – |
| FY2023 | Dec 31, 2023 | -$43.34M | – |
| FY2022 | Dec 31, 2022 | -$61.26M | – |
| FY2021 | Dec 31, 2021 | -$56.57M | – |
| FY2020 | Dec 31, 2020 | -$43.70M | – |
| FY2019 | Dec 31, 2019 | -$38.40M | – |
| FY2018 | Dec 31, 2018 | -$17.45M | – |
| FY2017 | Dec 31, 2017 | -$23.04M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.09M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.33M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.64M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.57M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.15M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.54M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.50M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.58M | – |
| Q2 FY2024 | Jun 30, 2024 | -$8.94M | – |
| Q1 FY2024 | Mar 31, 2024 | -$10.90M | – |
| Q4 FY2023 | Dec 31, 2023 | -$10.98M | – |
| Q3 FY2023 | Sep 30, 2023 | -$10.02M | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.21M | – |
| Q1 FY2023 | Mar 31, 2023 | -$11.13M | – |
| Q4 FY2022 | Dec 31, 2022 | -$11.18M | – |
| Q3 FY2022 | Sep 30, 2022 | -$14.16M | – |
| Q2 FY2022 | Jun 30, 2022 | -$18.51M | – |
| Q1 FY2022 | Mar 31, 2022 | -$17.41M | – |
| Q4 FY2021 | Dec 31, 2021 | -$14.48M | – |
| Q3 FY2021 | Sep 30, 2021 | -$15.87M | – |
| Q2 FY2021 | Jun 30, 2021 | -$13.98M | – |
| Q1 FY2021 | Mar 31, 2021 | -$12.24M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.98M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.47M | – |
| Q2 FY2020 | Jun 30, 2020 | -$12.47M | – |
| Q1 FY2020 | Mar 31, 2020 | -$12.77M | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.10M | – |
| Q3 FY2019 | Sep 30, 2019 | -$11.31M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.65M | – |
| Q1 FY2019 | Mar 31, 2019 | -$9.35M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.31M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.79M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.15M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.20M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.91M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.68M | – |
See a number that looks wrong?